Sean Laaman
Stock Analyst at Morgan Stanley
(4.67)
# 782
Out of 4,407 analysts
545
Total ratings
60.4%
Success rate
13.1%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics | Maintained: Buy | $34 | $27.75 | +22.52% | 4 | Jun 11, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | $30 | $13.70 | +118.98% | 9 | Jun 7, 2026 | |
| ABSI Absci | Maintained: Hold | $4.1 | $6.80 | -39.71% | 7 | Jun 2, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $94 → $98 | $66.80 | +46.71% | 6 | May 27, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 | $21.66 | +61.59% | 8 | May 26, 2026 | |
| CGON CG Oncology | Maintained: Buy | $93 | $59.56 | +56.15% | 13 | May 15, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $18 | $7.75 | +132.26% | 4 | May 15, 2026 | |
| SDGR Schrödinger | Maintained: Hold | $19 → $17 | $14.45 | +17.65% | 4 | May 14, 2026 | |
| IRON Disc Medicine | Rated: Buy | $75 → $80 | $67.99 | +17.66% | 11 | May 14, 2026 | |
| RXRX Recursion Pharmaceuticals | Maintained: Hold | $5 → $5.5 | $3.15 | +74.60% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $11.94 | +34.00% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $22 | $12.38 | +77.71% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 → $93 | $69.50 | +33.81% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,230 → $1,170 | $893.52 | +30.94% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $389 → $395 | $264.48 | +49.35% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $120 → $119 | $55.95 | +112.69% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $50 | $53.13 | -5.89% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 → $191 | $159.76 | +19.55% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $226 → $245 | $230.56 | +6.26% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $217 → $242 | $255.17 | -5.16% | 9 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.9 → $2 | $1.53 | +30.72% | 5 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $12 | $14.05 | -14.59% | 6 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $8.75 | +265.71% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $26 | $21.09 | +23.28% | 10 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $28.97 | +38.07% | 4 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $39.72 | -32.02% | 4 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.64 | +25.00% | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $5.20 | +207.69% | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.80 → $3.95 | $4.97 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $194.78 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.70 | $27.72 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310.00 | $107.51 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.60 → $31.65 | $20.20 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.38 → $24.14 | $29.27 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.99 → $27.94 | $39.45 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $276.00 → $256.00 | $103.75 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.30 | $0.36 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.15 → $7.35 | $6.99 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.45 → $1.65 | $0.685 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47.14 → $45.93 | $21.41 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53.60 → $51.60 | $38.82 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.70 → $2.75 | $2.04 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.32 | n/a | 2 | Aug 24, 2021 |
MapLight Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $34
Current: $27.75
Upside: +22.52%
Cullinan Therapeutics
Jun 7, 2026
Maintained: Buy
Price Target: $30
Current: $13.70
Upside: +118.98%
Absci
Jun 2, 2026
Maintained: Hold
Price Target: $4.1
Current: $6.80
Upside: -39.71%
BridgeBio Pharma
May 27, 2026
Maintained: Buy
Price Target: $94 → $98
Current: $66.80
Upside: +46.71%
Denali Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $35
Current: $21.66
Upside: +61.59%
CG Oncology
May 15, 2026
Maintained: Buy
Price Target: $93
Current: $59.56
Upside: +56.15%
BridgeBio Oncology Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $7.75
Upside: +132.26%
Schrödinger
May 14, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $14.45
Upside: +17.65%
Disc Medicine
May 14, 2026
Rated: Buy
Price Target: $75 → $80
Current: $67.99
Upside: +17.66%
Recursion Pharmaceuticals
May 14, 2026
Maintained: Hold
Price Target: $5 → $5.5
Current: $3.15
Upside: +74.60%
May 14, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $11.94
Upside: +34.00%
May 14, 2026
Maintained: Buy
Price Target: $20 → $22
Current: $12.38
Upside: +77.71%
May 12, 2026
Rated: Buy
Price Target: $96 → $93
Current: $69.50
Upside: +33.81%
May 8, 2026
Maintained: Buy
Price Target: $1,230 → $1,170
Current: $893.52
Upside: +30.94%
May 7, 2026
Maintained: Buy
Price Target: $389 → $395
Current: $264.48
Upside: +49.35%
May 6, 2026
Rated: Buy
Price Target: $120 → $119
Current: $55.95
Upside: +112.69%
May 6, 2026
Maintained: Hold
Price Target: $49 → $50
Current: $53.13
Upside: -5.89%
May 6, 2026
Reiterated: Hold
Price Target: $185 → $191
Current: $159.76
Upside: +19.55%
May 5, 2026
Maintained: Buy
Price Target: $226 → $245
Current: $230.56
Upside: +6.26%
May 5, 2026
Rated: Hold
Price Target: $217 → $242
Current: $255.17
Upside: -5.16%
May 4, 2026
Maintained: Sell
Price Target: $0.9 → $2
Current: $1.53
Upside: +30.72%
Mar 16, 2026
Maintained: Hold
Price Target: $10 → $12
Current: $14.05
Upside: -14.59%
Mar 3, 2026
Maintained: Buy
Price Target: $32
Current: $8.75
Upside: +265.71%
Feb 26, 2026
Maintained: Hold
Price Target: $25 → $26
Current: $21.09
Upside: +23.28%
Feb 26, 2026
Maintained: Hold
Price Target: $40
Current: $28.97
Upside: +38.07%
Nov 12, 2025
Maintained: Buy
Price Target: $27
Current: $39.72
Upside: -32.02%
Aug 28, 2025
Maintained: Buy
Price Target: $3.30
Current: $2.64
Upside: +25.00%
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $5.20
Upside: +207.69%
Feb 12, 2025
Maintained: Hold
Price Target: $3.80 → $3.95
Current: $4.97
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $194.78
Upside: n/a
Jun 24, 2024
Maintained: Buy
Price Target: $33.70
Current: $27.72
Upside: n/a
Jun 12, 2024
Maintained: Buy
Price Target: $310.00
Current: $107.51
Upside: n/a
May 22, 2024
Maintained: Buy
Price Target: $33.60 → $31.65
Current: $20.20
Upside: n/a
Apr 9, 2024
Maintained: Hold
Price Target: $25.38 → $24.14
Current: $29.27
Upside: n/a
Mar 22, 2024
Maintained: Hold
Price Target: $25.99 → $27.94
Current: $39.45
Upside: n/a
Mar 21, 2024
Maintained: Sell
Price Target: $276.00 → $256.00
Current: $103.75
Upside: n/a
Feb 28, 2024
Maintained: Sell
Price Target: $1.30
Current: $0.36
Upside: n/a
Feb 27, 2024
Maintained: Hold
Price Target: $8.15 → $7.35
Current: $6.99
Upside: n/a
Feb 26, 2024
Maintained: Buy
Price Target: $1.45 → $1.65
Current: $0.685
Upside: n/a
Jan 12, 2024
Maintained: Buy
Price Target: $47.14 → $45.93
Current: $21.41
Upside: n/a
Nov 28, 2023
Maintained: Hold
Price Target: $53.60 → $51.60
Current: $38.82
Upside: n/a
Aug 28, 2023
Maintained: Sell
Price Target: $2.70 → $2.75
Current: $2.04
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $14.32
Upside: n/a